Abstract
Colorectal cancer (CRC) is the third most diagnosed cancer in men (after prostate and lung cancers) and in women (after breast and lung cancer). It is the second cause of cancer death in men (after lung cancer) and the third one in women (after breast and lung cancers). It is estimated that, in EU-27 countries in 2020, colorectal cancer accounted for 12.7% of all new cancer diagnoses and 12.4% of all deaths due to cancer. Our study aims to assess the opportunistic colorectal cancer screening by colonoscopy in a private hospital. A secondary objective of this study is to analyse the adenoma detection rate (ADR), polyp detection rate (PDR), and colorectal cancer (CRC) detection rate. We designed a retrospective single-centre study in the Gastroenterology Department of Saint Mary Hospital. The study population includes all individuals who performed colonoscopies in 2 years, January 2019–December 2020, addressed to our department by their family physician or came by themselves for a colonoscopy. One thousand seven hundred seventy-eight asymptomatic subjects underwent a colonoscopy for the first time. The mean age was 59.0 ± 10.9, 59.5% female. Eight hundred seventy-three polyps were found in 525 patients. Five hundred and twenty-five had at least one polyp, 185 patients had two polyps, 87 had three polyps, and 40 patients had more than three polyps. The PDR was 49.1%, ADR 39.0%, advanced adenomas in 7.9%, and carcinomas were found in 5.4% of patients. In a country without any colorectal cancer screening policy, polyps were found in almost half of the 1778 asymptomatic patients evaluated in a single private center, 39% of cases adenomas, and 5.4% colorectal cancer. Our study suggests starting screening colonoscopy at the age of 45. A poor bowel preparation significantly impacted the adenoma detection rate.
Highlights
Colorectal cancer (CRC) is the third most frequent cancer in men and in women [1]
The patients above 50 years were sent by a physician for colonoscopy colorectal cancer screening check, as recommended by the guidelines when patients come into their cabinet for other medical conditions such as Diagnostics 2021, 11, 2393 liver steatosis, viral hepatitis, dyspepsia, and so on, even if they were asymptomatic for colorectal condition
The polyp detection rate (PDR) was 49.1%, adenoma detection rate (ADR) 39.0%, advanced adenomas in 7.9%, and carcinomas were found in 5.4% of patients (Table 2)
Summary
Colorectal cancer (CRC) is the third most frequent cancer in men (after prostate and lung cancers) and in women (after breast and lung cancer) [1] It is the second cause of cancer death in men (after lung cancer) and the third one in women (after breast and lung cancers). It is estimated that in European Cluster Collaboration Platform (EU-27) countries in 2020, colorectal cancer accounted for 12.7% of all new cancer diagnoses and 12.4% of all deaths due to cancer. This makes it the second most frequently occurring cancer (after breast cancer) and the second cause of cancer death (after lung cancer) in Europe. In part, be explained by different levels of healthcare expenditure and the resulting quality of screening, diagnosis, and treatment [2]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
